-
Gasperini's Roma future in doubt as infighting mars Champions League bid
-
Curacao World Cup qualification a 'divine journey': federation president
-
NBA fines Hornets' Ball for 'reckless' play on Adebayo
-
Val Kilmer returns via AI as filmmakers test Hollywood's red line
-
China's economy beats forecasts, but war darkens outlook
-
Latest team to fold sets Super Rugby up for another revamp
-
Iran participating in World Cup, FIFA president confirms
-
Police arrest two over London synagogue arson attempt
-
Syria's Kurds register for citizenship after decades of marginalisation
-
'There's more truth than fiction,' Spielberg says of 'Disclosure Day'
-
Strikes kill three in Ukraine, two in Russia, including children
-
Trump turmoil sees Spain's Sanchez emerge as progressive star
-
Pope to visit Cameroon conflict zone under high security
-
Luxury giant Kering to chart path for Gucci turnaround
-
Sixers top Magic to book NBA playoff clash with Celtics
-
Tokyo record leads Asia stocks higher as Iran peace hopes grow
-
India's 'Maharaja in Denims' stakes claim in AI film race
-
Russia rains strikes across Ukraine, killing three
-
US ex-Marine loses extradition appeal in China pilots case
-
Waratahs primed for physical Moana clash in front of Prince Harry
-
LIV Golf reassures players over Saudi withdrawal rumors
-
Much-hyped Alzheimer's drugs do not help patients, review finds
-
Mexican farmers raise alarm over Sheinbaum's fracking proposal
-
Brumbies gets Wright boost for Drua Super Rugby clash
-
Fuel supply fears after blaze tears through crucial Australian refinery
-
Trump's triumphal arch gets official name
-
Australia to boost defence spending citing growing threats
-
Left-winger Sanchez climbs to second place in Peru vote count
-
YouTube suspends pro-Iran channel posting Lego-style clips mocking Trump
-
US announces new sanctions against Iran oil sector
-
Longtime Messi friend Hoyos unveiled as Inter Miami coach
-
US optimistic about reaching peace deal with Iran
-
Kane lauds Diaz 'moment of magic' after Bayern knock out Real
-
'Beef' tackles generational conflicts in season 2: creator
-
'Beef 2' tackles generational conflicts in second season: creator
-
WNBA star Wilson signs record contract as league booms
-
Arteta confident in Arsenal after anxious progress to Champions League semis
-
Real slam 'unbelievable' red card after Bayern defeat
-
Rice 'doesn't care' about Arsenal critics after reaching Champions League semis
-
Bayern sink Real Madrid late to reach Champions League semis
-
Arsenal survive tense Sporting stalemate to reach Champions League semis
-
S&P 500, Nasdaq end at records as markets bet on US-Iran accord
-
Jury finds Ticketmaster owner ran illegal monopoly
-
US says optimistic about reaching peace deal with Iran
-
IMF and Argentina agree deal unlocking $1 bn in assistance
-
World Bank chief economist warns of hunger risk from war in Iran
-
France boss Deschamps confirms Ekitike to miss World Cup
-
Pope urges Cameroon's leaders to examine 'conscience'
-
'Fantastic feeling': Sudan capital returnees relieved after three years of war
-
France father who kept son in van faces 30 years in jail, says prosecutor
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
F.AbuZaid--SF-PST